
|Videos|May 24, 2021
Next-generation imaging and node-positive prostate cancer
Author(s)Urology Times staff
Advertisement
Jason Zhu, MD, a medical oncologist at Levine Cancer Institute, part of Atrium Health, discusses how next-generation imaging, such as PSMA-PET imaging, is critical to advancing personalized medicine in patients with lymph node–positive prostate cancer after prostatectomy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











